Skip to main content

Table 5 Risk of adverse outcomes and healthcare utilization according to frailty component individually

From: Both pre-frailty and frailty increase healthcare utilization and adverse health outcomes in patients with type 2 diabetes mellitus

Variables

Crude

Modela

HR

95% CI

HR

95% CI

Mortality

 Fatigue

1.3

1.27–1.34b

1.03

1.00–1.06c

 Resistance

2.24

2.09–2.4b

1.21

1.13–1.3b

 Ambulation

3.47

3.22–3.75b

1.06

0.98–1.15

 Illness

4.52

4.42–4.61b

0.99

0.96–1.02

 Body weight loss

4.03

3.83–4.23b

1.37

1.3–1.44b

Cardiovascular events

 Fatigue

1.21

1.18–1.24b

0.99

0.96–1.01

 Resistance

1.75

1.62–1.9b

1.09

1.00–1.17c

 Ambulation

2.69

2.47–2.94b

0.97

0.89–1.07

 Illness

4.68

4.58–4.78b

1.17

1.14–1.21b

 Body weight loss

2.21

2.07–2.36b

1.15

1.07–1.23b

Hospitalization

 Fatigue

1.25

1.24–1.26b

1.04

1.03–1.06b

 Resistance

1.71

1.64–1.77b

1.17

1.13–1.22b

 Ambulation

2.33

2.22–2.44b

1.13

1.08–1.19b

 Illness

2.82

2.79–2.86b

1.06

1.04–1.08b

 Body weight loss

2.09

2.02–2.16b

1.22

1.18–1.26b

ICU admission

 Fatigue

1.27

1.24–1.3b

1.01

0.99–1.04

 Resistance

2.04

1.9–2.18b

1.2

1.12–1.28b

 Ambulation

3.08

2.85–3.33b

1.07

0.99–1.16

 Illness

4.06

3.97–4.14b

1.03

1.00–1.06

 Body weight loss

3.03

2.87–3.19b

1.32

1.25–1.4b

  1. CI confidence interval, HR hazard ratio, ICU intensive care unit
  2. aAdjusted for demographic profiles, comorbidities, aDSCI, and medications
  3. bp < 0.001
  4. cp < 0.05